Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A non-inferiority (NI) trial is intended to show that the effect of a new treatment is not worse than the comparator. We conducted a review to identify how NI trials were conducted and reported, and whether the standard requirements from the guidelines were followed. METHODOLOGY AND PRINCIPAL FINDINGS: From 300 randomly selected articles on NI trials registered in PubMed at 5 February 2009, we included 227 NI articles that referred to 232 trials. We excluded studies on bioequivalence, trials on healthy volunteers, non-drug trials, and articles of which the full-text version could not be retrieved. A large proportion of trials (34.0%) did not use blinding. The NI margin was reported in 97.8% of the trials, but only 45.7% of the trials reported the method to determine the margin. Most of the trials used either intention to treat (ITT) (34.9%) or per-protocol (PP) analysis (19.4%), while 41.8% of the trials used both methods. Less than 10% of the trials included a placebo arm to confirm the efficacy of the new drug and active comparator against placebo, and less than 5.0% were reporting the similarity of the current trial with the previous comparator's trials. In general, no difference was seen in the quality of reporting before and after the release of the CONSORT statement extension 2006 or between the high-impact and low-impact journals. CONCLUSION: The conduct and reporting of NI trials can be improved, particularly in terms of maximizing the use of blinding, the use of both ITT and PP analysis, reporting the similarity with the previous comparator's trials to guarantee a valid constancy assumption, and most importantly reporting the method to determine the NI margin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement
Piaggio, G., Elbourne, D. R., Altman, D. G., Pocock, S. J., Evans, S. J. W., & CONSORT Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.10.1152 · Cited by 1,153 · cited 4×
“Quality of reporting To evaluate the quality of reporting, we compared the requirements from the extension of the CONSORT statement for NI and equivalence trials[10] between articles published before and after 2006 to evaluate the impact of the CONSORT statement extension on the reporting of NI trials.”
BackgroundMethodResultInfluentialTrials to assess equivalence: the importance of rigorous methods: Fig 1
Jones, B., Jarvis, P., Lewis, J. A., & Ebbutt, A. F. (1996) · BMJ · doi:10.1136/bmj.313.7048.36 · Cited by 1,032
Quality of Reporting of Noninferiority and Equivalence Randomized Trials
Le Henanff, A., Giraudeau, B., Baron, G., & Ravaud, P. (2006) · JAMA · doi:10.1001/jama.295.10.1147 · Cited by 263
Cited by
Jin, Y., Sanger, N., Shams, I., Luo, C., Shahid, H., Li, G., Bhatt, M., Zielinski, L., Bantoto, B., Wang, M., et al. (2018) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s155103 · Cited by 134
“Global score Wangge et al 138 12 Weingärtner et al 139 17 Weir et al 140 20 Wen et al 141 18 Willis and Quigley 142 20 Yao et al 143 16 Zafar et al 144 16 Zhang 145 18 Zhao et al 146 17 Zheng et al 147 18 Zhong et al 148 17 Zintzaras et al 149 18 Zintzaras et al 150 14 Ziogas and Zintzaras 15 1 15…”
Schiller, P., Burchardi, N., Niestroj, M., & Kieser, M. (2012) · Trials · doi:10.1186/1745-6215-13-214 · Cited by 53
Hernandez, A. V., Pasupuleti, V., Deshpande, A., Thota, P., Collins, J. A., & Vidal, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063272 · Cited by 29
“The clinical and statistical reasoning behind the selection of the appropriate NI margin is essential to be appropriately described in the manuscript [2,5,6].”
BackgroundMethodInfluential
Metadata
- Authors
- Wangge, G., Klungel, O. H., Roes, K. C. B., de Boer, A., Hoes, A. W., & Knol, M. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-10-27
- Volume
- 5
- Issue
- 10
- Pages
- e13550
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1990279013
- Cited by
- 90
- References
- 4
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review. https://app.cochat.ai/papers/10.1371/journal.pone.0013550
- The paper
- Wangge, G., Klungel, O. H., Roes, K. C. B., de Boer, A., Hoes, A. W., & Knol, M. J. (2010). Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review. PLoS ONE. https://doi.org/10.1371/journal.pone.0013550
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.